aspsirna3197 details

Purple = Wild vs mutant target sequence along with mutation information
Brown= Wild vs ASP-siRNA description along with positional differnece between two
Light pink= ASP siRNA efficacy for mutant vs wild allele
Green= Wild siRNA efficacy for Wild vs Mutant allele
siRNA Id:aspsirna3197
siRNA Name: siRNA-q
Gene:tumor protein p63 (TP63)
Disease:Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome 3 (EEC3)
Wild allele/target (5'->3'): ACGUGUCCUUCCAGCAGUC
Mutant allele/target (5'->3'):ACAUGUCCUUCCAGCAGUC
Target Mutation: p.Arg132His,c.394G>A
Wild siRNA (As strand):UGCACAGGAAGGUCGUCAG
ASP-siRNA (As strand):UGUACAGGAAGGUCGUCAG
Mismatch position in siRNA: U17C
Mutant allele (5'->3'): ACAUGUCCUUCCAGCAGUC
ASP-siRNA (As strand):UGUACAGGAAGGUCGUCAG
ASP-siRNA efficacy for mutant allele:40
Wild allele (5'->3'): ACGUGUCCUUCCAGCAGUC
ASP-siRNA (As strand):UGUACAGGAAGGUCGUCAG
ASP-siRNA efficacy for wild allele:30
Percentage discrimination for ASP-siRNA:10
Wild allele (5'->3'): ACGUGUCCUUCCAGCAGUC
Wild siRNA (As strand):UGCACAGGAAGGUCGUCAG
Wild sirna efficacy for wild allele:45
Wild allele (5'->3'): ACGUGUCCUUCCAGCAGUC
ASP-siRNA (As strand):UGUACAGGAAGGUCGUCAG
Wild sirna efficacy for mutant allele:65
Percentage discrimination for wild siRNA:-20
Concentration:100 microM
Orientation:Double strand
Mismatch in:siRNA
UniProt ID: Q9H3D4
Target sequence: CATCCCCTCCAACACCGACTACCCAGGCCCGCACAGTTTCGACG
Genbank Accesion: NM_001114980.1
Cell-line: HEK293T
Experimental technique used: Western blot
Transfection method: Lipofectamine 2000
siRNA expression method: Exiqon
Post-transfection duration: 72 hours
OMID ID: 604292
KEGG disease ID:NA
Reference:26891374

.
.
.
.
.
.
.
.
.
.
.

.

.

.